Insider Transactions Reported by 11 Insiders of Silexion Therapeutics Corp

Symbol
SLXN, SLXNW on Nasdaq
Location
Ramat Gan, Israel

There are no Buy or Sell transactions made by insiders since 12 Mar 2025

Silexion Therapeutics Corp executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Ilan Levin Director, 10%+ Owner $1,830,723 07 Aug 2025
Ilan Hadar Chairman and CEO, Director $162,081 20 Feb 2026
Mitchell Shirvan CSO and CDO $124,891 20 Feb 2026
Mirit Horenshtein Hadar CFO and Secretary $122,356 20 Feb 2026
Avner Lushi Director $88,044 20 Feb 2026
Shlomo Noy Director $88,044 20 Feb 2026
Ruth Alon Director $51,027 20 Feb 2026
Dror Yosef Abramov Director $50,910 20 Feb 2026
Amnon Peled Director $41,823 20 Feb 2026
Wildcat Capital Management, LLC 10%+ Owner 15 Aug 2024
Ilan Shiloah Director 15 Aug 2024

Recent Insider Transactions by Companies or Individuals for Silexion Therapeutics Corp

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Shlomo Noy SLXN Ordinary Shares Award 55.8% 9,091 25,399 20 Feb 2026 By Guangzhou Sino-Israel Biotech Fund
Shlomo Noy SLXN Stock Option (right to buy ordinary shares) Award 10,685 10,685 20 Feb 2026 By Guangzhou Sino-Israel Biotech Fund
Ruth Alon SLXN Ordinary Shares Award 799.6% 9,091 10,228 20 Feb 2026 Direct
Ruth Alon SLXN Stock Option (right to buy Ordinary Shares) Award 10,685 10,685 20 Feb 2026 Direct
Mitchell Shirvan SLXN Ordinary Shares Award 5068.9% 49,726 50,707 20 Feb 2026 Direct
Mirit Horenshtein Hadar SLXN Ordinary Shares Award 11839.5% 49,726 50,146 20 Feb 2026 Direct
Ilan Hadar SLXN Ordinary Shares Award 5740.4% 64,350 65,471 20 Feb 2026 Direct
Dror Yosef Abramov SLXN Ordinary Shares Award 834.8% 9,091 10,180 20 Feb 2026 Direct
Dror Yosef Abramov SLXN Stock Option (right to buy ordinary shares) Award 10,685 10,685 20 Feb 2026 Direct
Amnon Peled SLXN Ordinary Shares Award 1146.1% 7,576 8,237 20 Feb 2026 Direct
Amnon Peled SLXN Stock Option (right to buy Ordinary Shares) Award 8,904 8,904 20 Feb 2026 Direct
Avner Lushi SLXN Ordinary Shares Award 55.8% 9,091 25,399 20 Feb 2026 By Guangzhou Sino-Israel Biotech Fund
Avner Lushi SLXN Stock Option (right to buy ordinary shares) Award 10,685 10,685 20 Feb 2026 By Guangzhou Sino-Israel Biotech Fund
Ilan Levin SLXN Ordinary Shares Award 6456.2% 450,000 456,970 15 Sep 2025 By Moringa Sponsor, LP.
Ilan Levin SLXN Ordinary Shares Other -44.3% -5,550 6,970 07 Aug 2025 By Moringa Sponsor, LP.
Ilan Levin SLXN Warrant (right to buy) Other -71.5% -935 372 07 Aug 2025 By Moringa Sponsor, LP.
Dror Yosef Abramov SLXN Ordinary Shares Award 794 794 09 Feb 2025 Direct
Dror Yosef Abramov SLXN Stock Option (right to buy ordinary shares) Award 935 935 09 Feb 2025 Direct
Ruth Alon SLXN Ordinary Shares Award 794 794 09 Feb 2025 Direct
Ruth Alon SLXN Stock Option (right to buy ordinary shares) Award 935 935 09 Feb 2025 Direct
Shlomo Noy SLXN Ordinary Shares Award 1,587 1,587 09 Feb 2025 By Guangzhou Sino-Israel Biotech Fund
Shlomo Noy SLXN Stock Option (right to buy ordinary shares) Award 1,872 1,872 09 Feb 2025 By Guangzhou Sino-Israel Biotech Fund
Avner Lushi SLXN Ordinary Shares Award 1,587 1,587 09 Feb 2025 By Guangzhou Sino-Israel Biotech Fund
Avner Lushi SLXN Stock Option (right to buy ordinary shares) Award 1,872 1,872 09 Feb 2025 By Guangzhou Sino-Israel Biotech Fund
Amnon Peled SLXN Ordinary Shares Award 661 661 09 Feb 2025 Direct
Amnon Peled SLXN Stock Option (right to buy Ordinary Shares) Award 780 780 09 Feb 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.